Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Mesoporous silica nanoparticle-encapsulated Bifidobacterium attenuates brain Aβ burden and improves olfactory dysfunction of APP/PS1 mice by nasal delivery
by
Xie, Jun
, Yang, Changwen
, Liu, Ni
, Liang, Xiaohan
, Cao, Kai
, Luo, Qingming
, Luo, Haiming
in
Alzheimer Disease - pathology
/ Alzheimer's disease
/ Amyloid beta-Peptides - metabolism
/ Animal cognition
/ Animals
/ Bacteria
/ Bifidobacterium
/ Bifidobacterium - metabolism
/ Bile
/ Bile Acids and Salts
/ Biotechnology
/ Brain
/ Brain - metabolism
/ Chemistry
/ Chemistry and Materials Science
/ Cognitive ability
/ Digestive system
/ Disease Models, Animal
/ Dysbacteriosis
/ Fatty acids
/ Fatty Acids, Volatile
/ Fluorescence
/ Gastrointestinal system
/ Gastrointestinal tract
/ Hypotheses
/ Intestinal microflora
/ Intestine
/ Intranasal administration
/ Mesoporous silica nanospheres (MSNs)
/ Metabolites
/ Mice
/ Mice, Transgenic
/ Microbiomes
/ Microbiota
/ Molecular Medicine
/ Morphology
/ Nanoparticles
/ Nanospheres
/ Nanotechnology
/ Nasal delivery
/ Neurodegenerative diseases
/ Neuroimaging
/ Olfaction
/ Olfaction disorders
/ Olfaction Disorders - pathology
/ Olfactory thresholds
/ Oral administration
/ Pathogens
/ Permeability
/ Porous materials
/ Potassium
/ Presenilin 1
/ Probiotics
/ Salts
/ Silica
/ Silicon Dioxide
/ β-amyloid
2022
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Mesoporous silica nanoparticle-encapsulated Bifidobacterium attenuates brain Aβ burden and improves olfactory dysfunction of APP/PS1 mice by nasal delivery
by
Xie, Jun
, Yang, Changwen
, Liu, Ni
, Liang, Xiaohan
, Cao, Kai
, Luo, Qingming
, Luo, Haiming
in
Alzheimer Disease - pathology
/ Alzheimer's disease
/ Amyloid beta-Peptides - metabolism
/ Animal cognition
/ Animals
/ Bacteria
/ Bifidobacterium
/ Bifidobacterium - metabolism
/ Bile
/ Bile Acids and Salts
/ Biotechnology
/ Brain
/ Brain - metabolism
/ Chemistry
/ Chemistry and Materials Science
/ Cognitive ability
/ Digestive system
/ Disease Models, Animal
/ Dysbacteriosis
/ Fatty acids
/ Fatty Acids, Volatile
/ Fluorescence
/ Gastrointestinal system
/ Gastrointestinal tract
/ Hypotheses
/ Intestinal microflora
/ Intestine
/ Intranasal administration
/ Mesoporous silica nanospheres (MSNs)
/ Metabolites
/ Mice
/ Mice, Transgenic
/ Microbiomes
/ Microbiota
/ Molecular Medicine
/ Morphology
/ Nanoparticles
/ Nanospheres
/ Nanotechnology
/ Nasal delivery
/ Neurodegenerative diseases
/ Neuroimaging
/ Olfaction
/ Olfaction disorders
/ Olfaction Disorders - pathology
/ Olfactory thresholds
/ Oral administration
/ Pathogens
/ Permeability
/ Porous materials
/ Potassium
/ Presenilin 1
/ Probiotics
/ Salts
/ Silica
/ Silicon Dioxide
/ β-amyloid
2022
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Mesoporous silica nanoparticle-encapsulated Bifidobacterium attenuates brain Aβ burden and improves olfactory dysfunction of APP/PS1 mice by nasal delivery
by
Xie, Jun
, Yang, Changwen
, Liu, Ni
, Liang, Xiaohan
, Cao, Kai
, Luo, Qingming
, Luo, Haiming
in
Alzheimer Disease - pathology
/ Alzheimer's disease
/ Amyloid beta-Peptides - metabolism
/ Animal cognition
/ Animals
/ Bacteria
/ Bifidobacterium
/ Bifidobacterium - metabolism
/ Bile
/ Bile Acids and Salts
/ Biotechnology
/ Brain
/ Brain - metabolism
/ Chemistry
/ Chemistry and Materials Science
/ Cognitive ability
/ Digestive system
/ Disease Models, Animal
/ Dysbacteriosis
/ Fatty acids
/ Fatty Acids, Volatile
/ Fluorescence
/ Gastrointestinal system
/ Gastrointestinal tract
/ Hypotheses
/ Intestinal microflora
/ Intestine
/ Intranasal administration
/ Mesoporous silica nanospheres (MSNs)
/ Metabolites
/ Mice
/ Mice, Transgenic
/ Microbiomes
/ Microbiota
/ Molecular Medicine
/ Morphology
/ Nanoparticles
/ Nanospheres
/ Nanotechnology
/ Nasal delivery
/ Neurodegenerative diseases
/ Neuroimaging
/ Olfaction
/ Olfaction disorders
/ Olfaction Disorders - pathology
/ Olfactory thresholds
/ Oral administration
/ Pathogens
/ Permeability
/ Porous materials
/ Potassium
/ Presenilin 1
/ Probiotics
/ Salts
/ Silica
/ Silicon Dioxide
/ β-amyloid
2022
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Mesoporous silica nanoparticle-encapsulated Bifidobacterium attenuates brain Aβ burden and improves olfactory dysfunction of APP/PS1 mice by nasal delivery
Journal Article
Mesoporous silica nanoparticle-encapsulated Bifidobacterium attenuates brain Aβ burden and improves olfactory dysfunction of APP/PS1 mice by nasal delivery
2022
Request Book From Autostore
and Choose the Collection Method
Overview
Background
Dysbiosis or imbalance of gut microbiota in Alzheimer's disease (AD) affects the production of short-chain fatty acids (SCFAs), whereas exogenous SCFAs supplementation exacerbates brain Aβ burden in APP/PS1 mice.
Bifidobacterium
is the main producer of SCFAs in the gut flora, but oral administration of
Bifidobacterium
is ineffective due to strong acids and bile salts in the gastrointestinal tract. Therefore, regulating the levels of SCFAs in the gut is of great significance for AD treatment.
Methods
We investigated the feasibility of intranasal delivery of MSNs-
Bifidobacterium
(MSNs-Bi) to the gut and their effect on behavior and brain pathology in APP/PS1 mice.
Results
Mesoporous silica nanospheres (MSNs) were efficiently immobilized on the surface of
Bifidobacterium
. After intranasal administration, fluorescence imaging of MSNs-Bi in the abdominal cavity and gastrointestinal tract revealed that intranasally delivered MSNs-Bi could be transported through the brain to the peripheral intestine. Intranasal administration of MSNs-Bi not only inhibited intestinal inflammation and reduced brain Aβ burden but also improved olfactory sensitivity in APP/PS1 mice.
Conclusions
These findings suggested that restoring the balance of the gut microbiome contributes to ameliorating cognitive impairment in AD, and that intranasal administration of MSNs-Bi may be an effective therapeutic strategy for the prevention of AD and intestinal disease.
Publisher
BioMed Central,Springer Nature B.V,BMC
This website uses cookies to ensure you get the best experience on our website.